Dian Diagnostics Group Co.,Ltd. (300244.SZ)
CNY 12.69
(-0.47%)
CNY 12.69
(-0.47%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.93 Billion | 1.63 Billion | 1.31 Billion | 1.54 Billion | 483.18 Million | 373.23 Million |
| Net Income | 307.46 Million | 1.86 Billion | 1.48 Billion | 1.06 Billion | 575.56 Million | 588.46 Million |
| Depreciation & Amortization | 791.97 Million | 799.49 Million | 494.72 Million | 292.91 Million | 247.7 Million | 177.41 Million |
| Deferred income taxes | -123.94 Million | 84.4 Million | -92.97 Million | -32.65 Million | -18.41 Million | -33.92 Million |
| Stock-based compensation | 13.84 Million | 55.34 Million | 121.93 Million | 13.88 Million | - | - |
| Change in working capital | -40.14 Million | -2.63 Billion | -1.32 Billion | -607.36 Million | -720.48 Million | -647.95 Million |
| Other non-cash items | 2.62 Billion | 1.46 Billion | 632.29 Million | 810.52 Million | 380.4 Million | 255.31 Million |
| Investing Cash Flow | -625.66 Million | -1.07 Billion | -536.22 Million | -820.73 Million | -241.3 Million | -495.48 Million |
| Investments in PPE | -701.77 Million | -947.72 Million | -589.49 Million | -475.7 Million | -411.49 Million | -456.67 Million |
| Acquisitions | 39.13 Million | -64.5 Million | -40.65 Million | -31.08 Million | -63.61 Million | -385.71 Million |
| Investment purchases | -967.03 Million | -1.03 Billion | -389.27 Million | -507.24 Million | -4.65 Million | -62.39 Million |
| Sales/Maturities of investments | 1.02 Billion | 958.41 Million | 458.61 Million | 173.57 Million | 204.16 Million | 338.44 Million |
| Other Investing Activities | -20.47 Million | 14.98 Million | 24.58 Million | 19.72 Million | 34.3 Million | 70.85 Million |
| Financing Cash Flow | -2.5 Billion | 1.42 Billion | -309.99 Million | -256.36 Million | -676.28 Million | 1.02 Billion |
| Debt repayment | -2.05 Billion | -4.43 Billion | -4.85 Billion | -3.86 Billion | -2.76 Billion | -1.85 Billion |
| Dividends payments | -124.99 Million | -83.76 Million | -80.65 Million | -79.41 Million | -15.51 Million | -174.63 Million |
| Common Stock Repurchased | -40.96 Million | -9.03 Million | - | - | - | - |
| Common Stock Issuance | - | 9.03 Million | - | - | - | - |
| Other Financing Activities | -47.19 Million | 6.16 Billion | 4.81 Billion | 3.87 Billion | 2.31 Billion | 3.05 Billion |
| Accounts receivables | 1.96 Billion | -4.15 Billion | -2.03 Billion | 353.08 Million | -309.5 Million | -960.23 Million |
| Accounts payables | -2.06 Billion | 1.52 Billion | 1.02 Billion | -1.16 Billion | -229.44 Million | 569.66 Million |
| Inventory | 55.57 Million | -90.93 Million | -223.03 Million | 236.9 Million | -163.13 Million | -223.46 Million |
| Other working capital | 13.84 Million | 84.4 Million | -92.97 Million | -32.65 Million | -18.41 Million | -424.48 Million |
| Cash at beginning of period | 4.2 Billion | 2.14 Billion | 1.67 Billion | 1.21 Billion | 1.64 Billion | 746.58 Million |
| Cash at end of period | 2.97 Billion | 4.14 Billion | 2.14 Billion | 1.67 Billion | 1.21 Billion | 1.64 Billion |
| Capital Expenditure | -701.77 Million | -947.72 Million | -589.49 Million | -475.7 Million | -411.49 Million | -456.67 Million |
| Effect of forex changes on cash | 1.19 Million | 6.87 Million | -3.73 Million | -7.63 Million | 572.46 Thousand | 654.34 Thousand |
| Net cash flow / Change in cash | -1.22 Billion | 2 Billion | 467.97 Million | 462.48 Million | -433.83 Million | 901.69 Million |
| Free Cash Flow | 1.23 Billion | 691.64 Million | 728.41 Million | 1.07 Billion | 71.68 Million | -83.43 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 59.11 Million | 48.57 Million | 23.17 Million | 307.46 Million | -223.41 Million | 77.58 Million |
| Depreciation & Amortization | - | 177.22 Million | 177.22 Million | 791.97 Million | 229.9 Million | -283.86 Million |
| Deferred income taxes | - | - | - | -123.94 Million | - | 1.08 Billion |
| Stock-based compensation | - | 3.05 Million | - | 13.84 Million | 13.84 Million | -13.53 Million |
| Change in working capital | - | -845.11 Million | - | -40.14 Million | 2.03 Billion | -789.57 Million |
| Other non-cash items | 275.87 Million | 117.25 Million | -289.89 Million | 2.62 Billion | 2 Billion | 261.79 Million |
| Investing Cash Flow | -69.78 Million | -93.68 Million | -406.74 Million | -625.66 Million | -334.29 Million | -238.6 Million |
| Investments in PPE | -93.28 Million | -58.07 Million | -65.32 Million | -701.77 Million | -286.86 Million | -129.94 Million |
| Acquisitions | 10.4 Million | 18.11 Million | 56.27 Million | 39.13 Million | -73.12 Million | -26.53 Million |
| Investment purchases | -144.52 Million | -290.64 Million | -539.84 Million | -967.03 Million | -17.68 Million | -505.01 Million |
| Sales/Maturities of investments | 150.04 Million | 236.37 Million | 132 Million | 1.02 Billion | 92.63 Million | 416.6 Million |
| Other Investing Activities | 7.57 Million | 550 Thousand | 10.15 Million | -20.47 Million | -49.25 Million | 6.28 Million |
| Financing Cash Flow | -684.07 Million | -375.23 Million | -17.45 Million | -2.5 Billion | -492.09 Million | -735.75 Million |
| Debt repayment | -110.36 Million | -162.01 Million | -177.3 Million | -2.05 Billion | -459.22 Million | -1 Billion |
| Dividends payments | -449.27 Million | -37.16 Million | -48.98 Million | -124.99 Million | -124.99 Million | -52.65 Million |
| Common Stock Repurchased | 157.22 Million | -157.22 Million | - | -40.96 Million | -40.96 Million | 40.96 Million |
| Common Stock Issuance | - | - | - | - | - | -40.96 Million |
| Other Financing Activities | -124.44 Million | 69.32 Million | -194.75 Million | -47.19 Million | 393.72 Million | 324.89 Million |
| Accounts receivables | - | -780.6 Million | - | 1.96 Billion | 1.96 Billion | -713.51 Million |
| Accounts payables | - | - | - | -2.06 Billion | - | 7 Million |
| Inventory | - | -89.45 Million | - | 55.57 Million | 55.57 Million | -76.06 Million |
| Other working capital | - | 24.94 Million | - | 13.84 Million | 13.84 Million | -7 Million |
| Cash at beginning of period | 1.77 Billion | 2.27 Billion | 2.97 Billion | 4.2 Billion | 2.34 Billion | 2.85 Billion |
| Cash at end of period | 1.35 Billion | 1.77 Billion | 2.27 Billion | 2.97 Billion | 2.97 Billion | 2.22 Billion |
| Capital Expenditure | -93.28 Million | -58.07 Million | -65.32 Million | -701.77 Million | -286.86 Million | -129.94 Million |
| Effect of forex changes on cash | -4.42 Million | 1.47 Million | -2.51 Million | 1.19 Million | 1.15 Million | 201.29 Thousand |
| Net cash flow / Change in cash | -425.16 Million | -494.43 Million | -700.8 Million | -1.22 Billion | 632.11 Million | -635.19 Million |
| Free Cash Flow | 241.7 Million | -69.47 Million | -332.04 Million | 1.23 Billion | 1.26 Billion | 209.01 Million |
REY
8TRA
300339
KILITCH
BUVA
POR